Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Other financing activities (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Other financing activities for 7 consecutive years, with $1.0 million as the latest value for Q1 2025.

  • Quarterly Other financing activities rose 13.92% to $1.0 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2025, up 13.92% year-over-year, with the annual reading at $1.0 million for FY2025, 13.92% up from the prior year.
  • Other financing activities for Q1 2025 was $1.0 million at Precision Biosciences, up from $905000.0 in the prior quarter.
  • The five-year high for Other financing activities was $35.0 million in Q1 2021, with the low at -$35.0 million in Q2 2021.
  • Average Other financing activities over 4 years is $5.4 million, with a median of $1.0 million recorded in 2025.
  • The sharpest move saw Other financing activities skyrocketed 25447.45% in 2021, then grew 13.92% in 2025.
  • Over 4 years, Other financing activities stood at -$35.0 million in 2021, then skyrocketed by 170.91% to $24.8 million in 2022, then crashed by 96.35% to $905000.0 in 2024, then increased by 13.92% to $1.0 million in 2025.
  • According to Business Quant data, Other financing activities over the past three periods came in at $1.0 million, $905000.0, and $24.8 million for Q1 2025, Q1 2024, and Q3 2022 respectively.